All the news

Showing 10 of 318 articles from: Access to medicines & diagnostics

Get an RSS feed of these articles

Show

Increasing access to hepatitis C treatment in Ukraine

MSF / 09 June 2020
CHAI releases first-ever Hepatitis C Market Report

Clinton Health Access Initiative / 28 May 2020
The Medicines Patent Pool and Mylan sign agreement to scale up access to first generic version of hepatitis C treatment glecaprevir/pibrentasvir

Medicines Patent Pool / 24 February 2020
Malaysia: Stage set for access to Hepatitis C treatment

Star Online / 13 November 2019
Cost of Hepatitis C Drug Skyrockets 1,422% after Patent Approval

Folha de S.Paulo / 24 October 2019
Voluntary licensing of hepatitis C drugs has led to more people on treatment

Keith Alcorn / 28 August 2019

Voluntary licensing of hepatitis C treatments to generic drug manufacturers for sale in lower- and middle-income countries has increased the number of people treated by approximately 70 per thousand people diagnosed with hepatitis ...
Global hepatitis response gains ground – More action needed to achieve universal health coverage targets

World Health Organization / 12 April 2019
Armenia gets license to produce drugs for hepatitis C treatment

Public Radio of Armenia / 03 April 2019
Louisiana picks drug company for hepatitis C treatment plan

San Francisco Chronicle / 27 March 2019
Interview With Charles Gore, Medicines Patent Pool Executive Director

Intellectual Property Watch / 24 March 2019